These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo. Pyana Pati P; Van Reet N; Mumba Ngoyi D; Ngay Lukusa I; Karhemere Bin Shamamba S; Büscher P PLoS Negl Trop Dis; 2014 Oct; 8(10):e3212. PubMed ID: 25275572 [TBL] [Abstract][Full Text] [Related]
3. Chimerization at the AQP2-AQP3 locus is the genetic basis of melarsoprol-pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates. Graf FE; Baker N; Munday JC; de Koning HP; Horn D; Mäser P Int J Parasitol Drugs Drug Resist; 2015 Aug; 5(2):65-8. PubMed ID: 26042196 [TBL] [Abstract][Full Text] [Related]
4. Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol. Graf FE; Ludin P; Wenzler T; Kaiser M; Brun R; Pyana PP; Büscher P; de Koning HP; Horn D; Mäser P PLoS Negl Trop Dis; 2013; 7(10):e2475. PubMed ID: 24130910 [TBL] [Abstract][Full Text] [Related]
5. Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes. Baker N; Glover L; Munday JC; Aguinaga Andrés D; Barrett MP; de Koning HP; Horn D Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10996-1001. PubMed ID: 22711816 [TBL] [Abstract][Full Text] [Related]
6. Evolution, function and roles in drug sensitivity of trypanosome aquaglyceroporins. Quintana JF; Field MC Parasitology; 2021 Sep; 148(10):1137-1142. PubMed ID: 33602349 [TBL] [Abstract][Full Text] [Related]
7. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story. Baker N; de Koning HP; Mäser P; Horn D Trends Parasitol; 2013 Mar; 29(3):110-8. PubMed ID: 23375541 [TBL] [Abstract][Full Text] [Related]
8. Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Alghamdi AH; Munday JC; Campagnaro GD; Gurvic D; Svensson F; Okpara CE; Kumar A; Quintana J; Martin Abril ME; Milić P; Watson L; Paape D; Settimo L; Dimitriou A; Wielinska J; Smart G; Anderson LF; Woodley CM; Kelly SPY; Ibrahim HM; Hulpia F; Al-Salabi MI; Eze AA; Sprenger T; Teka IA; Gudin S; Weyand S; Field M; Dardonville C; Tidwell RR; Carrington M; O'Neill P; Boykin DW; Zachariae U; De Koning HP Elife; 2020 Aug; 9():. PubMed ID: 32762841 [TBL] [Abstract][Full Text] [Related]
10. Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs. Munday JC; Eze AA; Baker N; Glover L; Clucas C; Aguinaga Andrés D; Natto MJ; Teka IA; McDonald J; Lee RS; Graf FE; Ludin P; Burchmore RJ; Turner CM; Tait A; MacLeod A; Mäser P; Barrett MP; Horn D; De Koning HP J Antimicrob Chemother; 2014 Mar; 69(3):651-63. PubMed ID: 24235095 [TBL] [Abstract][Full Text] [Related]
11. Drug transport and drug resistance in African trypanosomes. Mäser P; Lüscher A; Kaminsky R Drug Resist Updat; 2003 Oct; 6(5):281-90. PubMed ID: 14643298 [TBL] [Abstract][Full Text] [Related]
12. Instability of aquaglyceroporin (AQP) 2 contributes to drug resistance in Trypanosoma brucei. Quintana JF; Bueren-Calabuig J; Zuccotto F; de Koning HP; Horn D; Field MC PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008458. PubMed ID: 32644992 [TBL] [Abstract][Full Text] [Related]
13. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate. Maina N; Maina KJ; Mäser P; Brun R Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis. Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303 [TBL] [Abstract][Full Text] [Related]
15. Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense. Graf FE; Ludin P; Arquint C; Schmidt RS; Schaub N; Kunz Renggli C; Munday JC; Krezdorn J; Baker N; Horn D; Balmer O; Caccone A; de Koning HP; Mäser P Cell Mol Life Sci; 2016 Sep; 73(17):3387-400. PubMed ID: 26973180 [TBL] [Abstract][Full Text] [Related]
16. Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein. Sanderson L; Dogruel M; Rodgers J; De Koning HP; Thomas SA J Pharmacol Exp Ther; 2009 Jun; 329(3):967-77. PubMed ID: 19261919 [TBL] [Abstract][Full Text] [Related]
17. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Nok AJ Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807 [TBL] [Abstract][Full Text] [Related]
18. Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance. Bernhard SC; Nerima B; Mäser P; Brun R Int J Parasitol; 2007 Nov; 37(13):1443-8. PubMed ID: 17602691 [TBL] [Abstract][Full Text] [Related]
19. Pentamidine Is Not a Permeant but a Nanomolar Inhibitor of the Trypanosoma brucei Aquaglyceroporin-2. Song J; Baker N; Rothert M; Henke B; Jeacock L; Horn D; Beitz E PLoS Pathog; 2016 Feb; 12(2):e1005436. PubMed ID: 26828608 [TBL] [Abstract][Full Text] [Related]
20. Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test. Stewart ML; Krishna S; Burchmore RJ; Brun R; de Koning HP; Boykin DW; Tidwell RR; Hall JE; Barrett MP Lancet; 2005 Aug 6-12; 366(9484):486-7. PubMed ID: 16084257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]